ClinicalTrials.gg
Drug

Selicrelumab clinical trials

Also written CP-870,893 and RO7009789.

studies test it
11
open now
1
in phase 3
0
first study started
2004

How each study uses selicrelumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the selicrelumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Selicrelumab
5

Development codes

CP-870,893
5
RO7009789
2
NSC 750268
1

Other names

CD40 agonist monoclonal antibody CP-870,893
1

Studies by the year they started

11 studies that test it; most in 2018 (2)

Studies that test selicrelumab, by start year
YearStudies
20041
20051
20091
20101
20121
20141
20161
20171
20182
20191

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 6

Hoffmann-La Roche (5) · Abramson Cancer Center at Penn Medicine (4) · H. Lee Moffitt Cancer Center and Research Institute (1) · The Lymphoma Academic Research Organisation (1)

Often tested with

Tested in the same studies.

Bevacizumab (3) · Albumin-Bound Paclitaxel (2) · Paclitaxel (2) · AB928 (2) · Tocilizumab (2) · Gemcitabine (1) · Cobimetinib (1) · PEGPH20 (1)

Studies

Open first, then newest update. How each study uses selicrelumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Given beside what is tested · 1 — selicrelumab is usual care or a partner of the new treatment

Codes

What other systems call selicrelumab · ClinicalTrials.gg INT005051

  • MeSH (NLM) C518149selicrelumabOne source NLM
  • UNII (FDA) 0O39RGI33VSELICRELUMABConfirmed FDA, NLM
  • NCI Thesaurus C119740SelicrelumabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.